Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BioChem Pharma and Adherex establish anticancer agreement

Aug. 25, 2000

AstraZeneca receives patent for new series of pyrimidine compounds

Aug. 24, 2000

PKC inhibitors under study at Kyowa Hakko

Aug. 24, 2000

Cancer researchers reveal extended activity of tyrosine kinase inhibitor

Aug. 24, 2000

Aronex's amended Atragen NDA accepted for FDA review

Aug. 23, 2000

Abbott describes novel selective MMP-2/MMP-9 inhibitors

Aug. 23, 2000

Kinase inhibitors demonstrate apoptotic activity in chronic lymphocytic leukemia

Aug. 23, 2000

Protein levels indicate severity of prostate cancer tumors

Aug. 23, 2000

NIH licensing opportunity: radiation therapy optimization technology

Aug. 23, 2000

Inex's Onco TCS given fast track status

Aug. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...